<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">endofocus</journal-id><journal-title-group><journal-title xml:lang="ru">FOCUS Эндокринология</journal-title><trans-title-group xml:lang="en"><trans-title>FOCUS. Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-0177</issn><issn pub-type="epub">2713-0185</issn><publisher><publisher-name>ООО "Издательство "Перо"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.62751/2713-0177-2025-6-2-02</article-id><article-id custom-type="elpub" pub-id-type="custom">endofocus-139</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Особенности суточного профиля артериального давления у молодых мужчин с ожирением</article-title><trans-title-group xml:lang="en"><trans-title>Features of the daily blood pressure profile in obese young men</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6826-5924</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Теплова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Teplova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Теплова Анна Сергеевна – ассистент кафедры эндокринологии</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Anna S. Teplova – assistant at the Department of endocrinology of the Institute of Clinical Medicine</p><p>Moscow</p></bio><email xlink:type="simple">anna_kochina_@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-0429-0777</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хидирова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Khidirova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хидирова Лейла Самировна – студент</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Leyla S. Khidirova – student</p><p>Moscow</p></bio><email xlink:type="simple">anna_kochina_@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2025</year></pub-date><volume>6</volume><issue>2</issue><issue-title>Кардиоэндокринология</issue-title><elocation-id>12–20</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Теплова А.С., Хидирова Л.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Теплова А.С., Хидирова Л.С.</copyright-holder><copyright-holder xml:lang="en">Teplova A.S., Khidirova L.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://endofocus.elpub.ru/jour/article/view/139">https://endofocus.elpub.ru/jour/article/view/139</self-uri><abstract><p>Актуальность. Артериальная гипертензия (АГ) у пациентов с ожирением часто носит маскированный (скрытый) характер и проявляется повышением артериального давления (АД) в ночные часы, что затрудняет диагностику этого заболевания при офисном измерении АД. Суточный мониторинг артериального давления (СМАД) служит эффективным инструментом диагностики АГ и оценки эффективности лечения у пациентов с ожирением.Цель. Выявить особенности профиля АГ по данным СМАД у молодых пациентов мужского пола, страдающих ожирением.Материалы и методы. Проведено проспективное наблюдательное исследование, в которое были включены 102 пациента мужского пола с АГ и ожирением, госпитализированные в эндокринологическое отделение ГБУЗ ГКБ им. В.П. Демихова по направлению районного военного комиссариата с целью дообследования по поводу ожирения.Результаты. Медиана возраста участников исследования составила 23 [21; 25] года, индекса массы тела (ИМТ) – 40 [32; 53] кг/м2. На момент пребывания в стационаре пациенты не получали антигипертензивную терапию. В группах пациентов с ожирением 2 и 3 степени медианы среднесуточных показателей составили соответственно 125,00 [105,50; 131,00] и 129,00 [120,50; 136,50] мм рт. ст. для систолического АД (р=0,180) и 80,00 [75,00; 89,00] и 81,00 [73,50; 89,75] мм рт. ст. для диастолического АД (р=0,937). Анализ распределения пациентов по типу суточной кривой показал, что 31,4% (n=32) из них относились к типу «диппер», 52,9% (n=54) – к «нон-дипперам», 8,8% (n=9) – к «найт-пикерам», 6,9% (n=7) – к «овер-дипперам». Распределение медиан ИМТ в данных группах выглядело следующим образом: 39,45 [37,08; 42,40], 40,60 [38,35; 41,65], 39,40 [37,80; 39,90] и 40,10 [39,75;45,25] кг/м2 соответственно.Заключение. Большинство исследованных пациентов по типу суточной кривой относились к «нон-дипперам», то есть имели недостаточное снижение АД в ночные часы. Кроме того, у более половины пациентов отмечалась ночная АГ, что является фактором риска неблагоприятных сердечно-сосудистых исходов.</p></abstract><trans-abstract xml:lang="en"><p>Background. Arterial hypertension (AH) in obese patients is often masked (hidden) and is manifested by an increase in blood pressure (BP) at night, which makes it difficult to with office blood pressure measurement. Ambulatory blood pressure monitoring (ABPM) is an effective tool for diagnosing hypertension and evaluating the effectiveness of treatment in obese patients.The aim: to identify the features of the hypertension profile according to the ABPM data in obese young male patients.Materials and methods. A prospective observational study was conducted, which included 102 male patients with hypertension and obesity who were hospitalized in the endocrinology department of the V.P. Demikhov State Clinical Hospital.Results. The median age of the patients was 23 [21; 25] years; body mass index (BMI) 40 [32; 53] kg/m2. The patients did not receive antihypertensive therapy. In the groups of patients with grade 2 and 3 obesity, the median daily averages were 125.00 [105.50; 131.00] and 129.00 [120.50; 136.50] mmHg, respectively, for SBP (p=0.180) and 80.00 [75.00; 89.00] and 81.00 [73.50; 89.75] mmHg for DBP (p=0.937). 31.4% (n=32) of patients are of the "dipper" type, 52.9% (n=54) are "non-dippers", 8.8% (n=9) are "night pickers", 6.9% (n=7) "over-dippers". The median BMI in these groups was as follows: 39.45 [37.08; 42.40], 40.60 [38.35; 41.65], 39.40 [37.80; 39.90] and 40.10 [39.75; 45.25] kg/m2, respectively.Conclusions. Most patients are classified as "non-dippers", that is, they have an insufficient decrease in blood pressure at night, in addition, more than half of the patients have nocturnal hypertension, which is a risk factor for adverse cardiovascular outcomes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>артериальная гипертензия</kwd><kwd>суточный мониторинг артериального давления</kwd><kwd>ночная артериальная гипертензия</kwd><kwd>маскированная артериальная гипертензия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>arterial hypertension</kwd><kwd>daily blood pressure monitoring</kwd><kwd>nocturnal arterial hypertension</kwd><kwd>masked arterial hypertension</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чумакова Г.А., Кузнецова Т.Ю., Дружилов М.А. Многоликость артериальной гипертензии при ожирении. Российский кардиологический журнал. 2023; 28(4): 62–68. doi:10.15829/1560-4071-2023-5360.</mixed-citation><mixed-citation xml:lang="en">Чумакова Г.А., Кузнецова Т.Ю., Дружилов М.А. Многоликость артериальной гипертензии при ожирении. Российский кардиологический журнал. 2023; 28(4): 62–68. doi:10.15829/1560-4071-2023-5360.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Демидова Т.Ю., Грицкевич Е.Ю. Ожирение и артериальная гипертензия: механизмы и возможности управления. FOCUS Эндокринология. 2020; 1(1): 52–59. doi: 10.47407/ef2020.1.1.0007.</mixed-citation><mixed-citation xml:lang="en">Демидова Т.Ю., Грицкевич Е.Ю. Ожирение и артериальная гипертензия: механизмы и возможности управления. FOCUS Эндокринология. 2020; 1(1): 52–59. doi: 10.47407/ef2020.1.1.0007.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hall JE, do Carmo JM, da Silva AA et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015; 116(6): 991–1006. doi: 10.1161/CIRCRESAHA.116.305697.</mixed-citation><mixed-citation xml:lang="en">Hall JE, do Carmo JM, da Silva AA et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015; 116(6): 991–1006. doi: 10.1161/CIRCRESAHA.116.305697.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Para I, Albu A, Porojan MD. Adipokines and arterial stiffness in obesity. Medicina (Kaunas). 2021; 57(7): 653. doi: 10.3390/medicina57070653.</mixed-citation><mixed-citation xml:lang="en">Para I, Albu A, Porojan MD. Adipokines and arterial stiffness in obesity. Medicina (Kaunas). 2021; 57(7): 653. doi: 10.3390/medicina57070653.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hall JE, Mouton AJ, da Silva AA et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021; 117(8): 1859–76. doi: 10.1093/cvr/cvaa336.</mixed-citation><mixed-citation xml:lang="en">Hall JE, Mouton AJ, da Silva AA et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021; 117(8): 1859–76. doi: 10.1093/cvr/cvaa336.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017; 956: 61–84. doi:10.1007/5584_2016_147.</mixed-citation><mixed-citation xml:lang="en">Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017; 956: 61–84. doi:10.1007/5584_2016_147.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jin N, Huang L, Hong J et al. The association between systemic inflammation markers and the prevalence of hypertension. BMC Cardiovasc Disord. 2023; 23(1): 615. doi: 10.1186/s12872-023-03661-6.</mixed-citation><mixed-citation xml:lang="en">Jin N, Huang L, Hong J et al. The association between systemic inflammation markers and the prevalence of hypertension. BMC Cardiovasc Disord. 2023; 23(1): 615. doi: 10.1186/s12872-023-03661-6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Mol Cell. 2021; 81(18): 3708–30. doi: 10.1016/j.molcel.2021.08.027.</mixed-citation><mixed-citation xml:lang="en">Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity. Mol Cell. 2021; 81(18): 3708–30. doi: 10.1016/j.molcel.2021.08.027.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Xia JH, Zhang DY, Kang YY et al. The prevalence of masked hypertension and masked uncontrolled hypertension in relation to overweight and obesity in a nationwide registry in China. Hypertens Res. 2022; 45(11): 1690–700. doi: 10.1038/s41440-022-01005-z.</mixed-citation><mixed-citation xml:lang="en">Xia JH, Zhang DY, Kang YY et al. The prevalence of masked hypertension and masked uncontrolled hypertension in relation to overweight and obesity in a nationwide registry in China. Hypertens Res. 2022; 45(11): 1690–700. doi: 10.1038/s41440-022-01005-z.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fujiwara T, Hoshide S, Sheppard JP et al. Cardiovascular events risk in officemasked nocturnal hypertension defined by home blood pressure monitoring. JACC Adv. 2024; 3(11): 101352. doi: 10.1016/j.jacadv.2024.101352.</mixed-citation><mixed-citation xml:lang="en">Fujiwara T, Hoshide S, Sheppard JP et al. Cardiovascular events risk in officemasked nocturnal hypertension defined by home blood pressure monitoring. JACC Adv. 2024; 3(11): 101352. doi: 10.1016/j.jacadv.2024.101352.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж.Д., Троицкая Е.А. Нарушения профиля ночного артериального давления: значение, возможности диагностики, терапевтические подходы. Российский кардиологический журнал. 2024; 29(11): 141–154. doi: 10.15829/1560-4071-2024-6159.</mixed-citation><mixed-citation xml:lang="en">Кобалава Ж.Д., Троицкая Е.А. Нарушения профиля ночного артериального давления: значение, возможности диагностики, терапевтические подходы. Российский кардиологический журнал. 2024; 29(11): 141–154. doi: 10.15829/1560-4071-2024-6159.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж.Д., Конради А.О., Недогода С.В. с соавт. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(9): 230–329. doi: 10.15829/1560-4071-2024-6117.</mixed-citation><mixed-citation xml:lang="en">Кобалава Ж.Д., Конради А.О., Недогода С.В. с соавт. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(9): 230–329. doi: 10.15829/1560-4071-2024-6117.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018; 71(6): 1269–324. doi: 10.1161/HYP.0000000000000066.</mixed-citation><mixed-citation xml:lang="en">Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018; 71(6): 1269–324. doi: 10.1161/HYP.0000000000000066.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kario K, Hoshide S, Nagai M et al. Sleep and cardiovascular outcomes in relation to nocturnal hypertension: The J-HOP Nocturnal Blood Pressure Study. Hypertens Res. 2021; 44(12): 1589–96. doi: 10.1038/s41440-021-00709-y.</mixed-citation><mixed-citation xml:lang="en">Kario K, Hoshide S, Nagai M et al. Sleep and cardiovascular outcomes in relation to nocturnal hypertension: The J-HOP Nocturnal Blood Pressure Study. Hypertens Res. 2021; 44(12): 1589–96. doi: 10.1038/s41440-021-00709-y.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина В.Н., Федорова Е.В., Кульбачинская О.М. Утренний подъем артериального давления: обзор отечественной и зарубежной литературы. Лечебное дело. 2019; (3): 66–72. doi: 10.24411/2071-5315-2019-12143.</mixed-citation><mixed-citation xml:lang="en">Ларина В.Н., Федорова Е.В., Кульбачинская О.М. Утренний подъем артериального давления: обзор отечественной и зарубежной литературы. Лечебное дело. 2019; (3): 66–72. doi: 10.24411/2071-5315-2019-12143.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kaul U, Bhagwat A, Omboni S et al. Blood pressure and heart rate related to sex in untreated subjects: The India ABPM study. J Clin Hypertens (Greenwich). 2020; 22(7): 1154–62. doi: 10.1111/jch.13894.</mixed-citation><mixed-citation xml:lang="en">Kaul U, Bhagwat A, Omboni S et al. Blood pressure and heart rate related to sex in untreated subjects: The India ABPM study. J Clin Hypertens (Greenwich). 2020; 22(7): 1154–62. doi: 10.1111/jch.13894.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hamadou B, Amougou SN, Tchuendem Y et al. Prevalence and determinants of masked hypertension among obese individuals at the Yaounde Central Hospital: A cross-sectional study in sub-Saharan Africa. Blood Press Monit. 2020; 25(4): 212–15. doi: 10.1097/MBP.0000000000000457.</mixed-citation><mixed-citation xml:lang="en">Hamadou B, Amougou SN, Tchuendem Y et al. Prevalence and determinants of masked hypertension among obese individuals at the Yaounde Central Hospital: A cross-sectional study in sub-Saharan Africa. Blood Press Monit. 2020; 25(4): 212–15. doi: 10.1097/MBP.0000000000000457.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lipski D, Marzynska D, Sytek P et al. Obesity in hypertensive patients is characterized by a dawn phenomenon in systolic blood pressure values and variability. J Clin Med. 2024; 13(2): 371. doi: 10.3390/jcm13020371.</mixed-citation><mixed-citation xml:lang="en">Lipski D, Marzynska D, Sytek P et al. Obesity in hypertensive patients is characterized by a dawn phenomenon in systolic blood pressure values and variability. J Clin Med. 2024; 13(2): 371. doi: 10.3390/jcm13020371.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">[Palmeira NGF, Bianco HT, Bombig MTN et al. Association between morning surge and left ventricular hypertrophy in obese hypertensive patients. Arq Bras Cardiol. 2023; 120(9): e20230050 (In English, Portuguese)]. doi: 10.36660/abc.20230050.</mixed-citation><mixed-citation xml:lang="en">[Palmeira NGF, Bianco HT, Bombig MTN et al. Association between morning surge and left ventricular hypertrophy in obese hypertensive patients. Arq Bras Cardiol. 2023; 120(9): e20230050 (In English, Portuguese)]. doi: 10.36660/abc.20230050.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pucci G, D'Abbondanza M, Camilli M et al. Assessment of nocturnal hypertension by ambulatory blood pressure monitoring at the forearm in people with morbid obesity. J Clin Hypertens (Greenwich). 2020; 22(9): 1538–45. doi: 10.1111/jch.13983.</mixed-citation><mixed-citation xml:lang="en">Pucci G, D'Abbondanza M, Camilli M et al. Assessment of nocturnal hypertension by ambulatory blood pressure monitoring at the forearm in people with morbid obesity. J Clin Hypertens (Greenwich). 2020; 22(9): 1538–45. doi: 10.1111/jch.13983.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mathews HF, Kumar S, Madhu B et al. The ambulatory blood pressure monitoring among obese and nonobese diabetes mellitus patients. Ann Afr Med. 2022; 21(3): 255–61. doi: 10.4103/aam.aam_65_21.</mixed-citation><mixed-citation xml:lang="en">Mathews HF, Kumar S, Madhu B et al. The ambulatory blood pressure monitoring among obese and nonobese diabetes mellitus patients. Ann Afr Med. 2022; 21(3): 255–61. doi: 10.4103/aam.aam_65_21.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Naser N, Dzubur A, Durak A et al. Blood pressure control in hypertensive patients, cardiovascular risk profile and the prevalence of masked uncontrolled hypertension (MUCH). Med Arch. 2016; 70(4): 274–79. doi: 10.5455/medarh.2016.70.274-279.</mixed-citation><mixed-citation xml:lang="en">Naser N, Dzubur A, Durak A et al. Blood pressure control in hypertensive patients, cardiovascular risk profile and the prevalence of masked uncontrolled hypertension (MUCH). Med Arch. 2016; 70(4): 274–79. doi: 10.5455/medarh.2016.70.274-279.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
